Navigation Links
Free IVF Treatment Could Prove Beneficial to the Society And Its Economy

A new research was conducted by Professor William Ledger, a fertility expert at the University of Sheffield who studied the average cost of producing //a baby through in-vitro fertilisation and the benefit to the government over the person's lifetime. The study states that the benefits of providing free fertility treatments to couples could compensate by far the costs to the government.

He along with a group of mathematicians and economists used a modelling exercise and calculated that for the average 13,000 pounds it would cost to provide treatment of in-vitro fertilisation (IVF) the government would recoup 143,000 pounds in taxes alone.

Addressing a news conference he said, "Helping people with infertility have children is not just a benefit to themselves and their families but also to society," He further added that there would be a huge net positive benefit to the society over that child's lifetime.

Ledger while explaining that the availability of government-funded fertility treatment varies across the country, he said that the treatment was currently less than one per eligible infertile couple. But he explained if it could be increased to at least three treatments per couple, then over the next two to three years the number of babies born through IVF could increase by 10,000.

He then went on to explain that assuming the person was born as an IVF child to a mother of about 35 years of age would over a lifetime normally contribute 143,000 pounds to the state in benefits. Reports show that in the year of 2006 in Britain a live birth happens in about one treatment cycle in four.

Meanwhile in a separate research that was presented at the European Society of Human Reproduction and Embryology (ESHRE), an independent research organisation RAND Europe, had suggested that if European governments start to provide more fertility treatments for infertile couples it could then compensate the population ageing crisis
'"/>




Page: 1 2

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
(Date:11/20/2008)...ER 2008 The consumption of illicit or noncommerci...de and contributes significantly to the global bur... today by the International Center for Alcohol Pol...commercial alcohol, defined as traditional beverag...trade and counterfeit or unregistered products, in...
(Date:11/20/2008)...rmone worsened respiratory disease , , T... of estrogen during ovulation may explain why wome... with the respiratory disease, researchers at the ...hors of the study, published in the Nov. 20 issue ...t that drugs that reduce estrogen levels, such as ...
(Date:11/20/2008)...pkins Bloomberg School of Public Health and The Ne...mposium to mark the 60th Anniversary of the Univer...c Health and Human Rights: The Work Ahead of Us," ...rights over the last 60 years. , Navanethem Pill... for Human Rights will be the keynote speaker. , ...
(Date:11/20/2008).../ -- The UNICEF supported clean-water,campaign kn... technology,manufacturer, The Watergeeks Laborato...paign in 2009 -- the third year of this award-winn...e clean water to children around the world. , ...nufacturer will donate a,percentage of the on-lin...
Breaking Medicine News(10 mins):Health News:Report finds extensive use of illicit alcohol 2Health News:Estrogen May Explain Why Women With Cystic Fibrosis Suffer More 2Health News:Estrogen May Explain Why Women With Cystic Fibrosis Suffer More 3Health News:TAP Project Partners With Watergeeks for 2009 Clean Water Campaign 2Health News:TAP Project Partners With Watergeeks for 2009 Clean Water Campaign 3
...New Zealand are not getting enough sun, and as a r...ted conditions// are making a comeback, experts ha...alia. “Vitamin D deficiency and nutritional ricket...ic health issues in Australia and New Zealand,” sa...
...’ scandals, the patients who received tendons, car...e being advised to undergo tests for hepatitis and...ear. Since the federal officials won’t tell the n...ho had got tissue before the recalls were announce...
... an outbreak of the deadly bird flu following repo...tes.// The first of these cases was reported in th...me 490 kilometers or 305 miles south of Cairo. Fo...poultry on the farm were slaughtered and tests are...
... decided to spend US$2 million to curb a massive e... nurses from the country.// This amount was alloc...tion package. The state-controlled Herald was told...special government taskforce on skills retention, ...
Other Medicine News:Health News:More Sunshine for At-Risk Kids 2Health News:Tissue implant scandal heightens FDA’s concer 2Health News:Incentives to stop Zimbabwe skills exodus 2
(Date:11/20/2008)..., , , , PHILADELPHIA, Nov. 20 /PRNew...today announced that the United States Food and Dr...al for PROMACTA(R) (eltrombopag) for the treatment...ne (idiopathic) thrombocytopenic purpura (ITP) who...ids, immunoglobulins or splenectomy. The approval ...
(Date:11/20/2008)... JOLLA, Calif., Nov. 20 ...KA), announced today that it has submitted its,pi...eview under a Special,Protocol Assessment (SPA) p...n,(FDA). , Subject to securing an agreemen...e, prospective, double-blind, placebo-controlled a...
(Date:11/19/2008)...N FRANCISCO, Nov. 19 Posit Science...idence at the Society for Neuroscience,Annual Con...t cognitive,training may benefit Baby Boomers. T...ess Program (TM) uses adaptive exercises that targ...are designed to drive generalized,improvements in...
(Date:11/19/2008)...WARK, Del., Nov. 19 Isogen, a cont...or sterile filling, today announced the first,pha...ogen was founded to,specifically address the proc...ciated with the $2 billion highly-niched, low-volu...lling market segment. , Companies can inves...
Breaking Medicine Technology:FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Isogen Launches Major New Facility to Address Global Biopharma Demand 2PCMA Launches New Print Ad Campaign Highlighting Costs Associated With the Independent Drugstore Lobbys Agenda 7761 1David Luci Joins MacroChem as General Counsel and Vice President Corporate Development 7758 1David Luci Joins MacroChem as General Counsel and Vice President Corporate Development 7758 2David Luci Joins MacroChem as General Counsel and Vice President Corporate Development 7758 3David Luci Joins MacroChem as General Counsel and Vice President Corporate Development 7758 4Angiotech to participate in RBC 2007 Healthcare Conference 2094 1Diabetes Linked to Blood Vessel Inflammation 7756 1Diabetes Linked to Blood Vessel Inflammation 7756 2
...007 /PRNewswire/ -- LigoCyte,Pharmaceuticals prese...ion with their influenza virus-like particles (VLP...allenge study. The,company,s data were presented b...accine development, at the Tenth Annual Conference...ndation of Infectious,Diseases in Baltimore. , The...
...IRE)--May 3, 2007 - Insmed Inc.,(Nasdaq:INSM) toda...tigator-sponsored study of the company,s drug, IPL...hy (DM1)., Preliminary results of the clinical stu... School of Medicine and Dentistry,showed that six...g/kg/day in six patients met the primary study end...
Other Medicine Technology:LigoCyte Pharmaceuticals Presents Data Showing Heterosubtypic,Protection Against Influenza Challenge With Virus-Like Particle,Immunization 2Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 2Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 3Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 4
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs).
...d generation tissue valve from Medtronic, is the o...e. The Mosaic valve builds upon three decades of t...for patients who require aortic or mitral valve re...ars, Medtronics mitral valves have incorporated a ...
Medtronic Aortic Punches are intended for use by cardiac surgeons during coronary artery bypass grafting procedures to create an opening in the wall of the vessel. All punches are sterile and disposa
Implantable defibrillators are used to treat heart rhythms that are abnormally fast and life threatening. Implantable cardioverter defibrillators (ICDs) often are used to treat sudden cardiac death (
Medicine Products: